Can I read Use of Teduglutide in Adults with Short Bowel Syndrome–associated Intestinal Failure on EtoBox?

Use of Teduglutide in Adults with Short Bowel Syndrome–associated Intestinal Failure by Loris Pironi; Johane P. Allard; Francisca Joly; Parnia Geransar; Elisabeth Genestin; Ulrich‐Frank Pape is a Medicine article available to read on EtoBox.

What is Use of Teduglutide in Adults with Short Bowel Syndrome–associated Intestinal Failure about?

## Abstract Short bowel syndrome (SBS) is a rare gastrointestinal disorder associated with intestinal failure (SBS‐IF) and poor health‐related outcomes. Patients with SBS‐IF are unable to absorb sufficient nutrients or fluids to maintain significantly metabolic homeostasis via oral or enteral intake alone and require long‐term intravenous supplementation (IVS), consisting of partial or total parenteral nutrition, fluids, electrolytes, or a combination of these. The goal of medical and surgical treatment for patients with SBS‐IF is to maximize intestinal remnant absorptive capacity so that the need for IVS support may eventually be reduced or eliminated. Daily subcutaneous administration of the glucagon‐like peptide 2 analog, teduglutide, has been shown to be clinically effective in reducing IVS dependence and potentially improving the health‐related quality of life of patients with SBS‐IF. The management of patients with SBS‐IF is complex and requires close monitoring. This narrative review discusses the use of teduglutide for patients with SBS‐IF in clinical practice. The screening of patient eligibility for teduglutide treatment, initiation, monitoring of efficacy and safety of t

Who reads Use of Teduglutide in Adults with Short Bowel Syndrome–associated Intestinal Failure?

Author

Loris Pironi; Johane P. Allard; Francisca Joly; Parnia Geransar; Elisabeth Genestin; Ulrich‐Frank Pape

Publisher

Wiley

Published

2023

Language

EN

Field

Medicine (Health Sciences)